Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Charles Lister, providing advice to Lord Hunt regarding the Hepatitis C litigation against the National Blood Authority, noted that settlement of that litigation (or an award of damages by the court) would give rise to "inevitable claims of inequity from the Haemophilia Society".
Published on:
15 August, 2024
Lord Hunt noted a clear and defendable distinction between settlement of litigation and the Government's continued refusal to compensate people with haemophilia infected with HCV through blood products on the basis of non-negligent harm.
Published on:
15 August, 2024
In October 2000, Lord Hunt sought advice on what could be offered in terms of a package of care for victims of HCV, as noted in an email chain from Sue Cartwright to Charles Lister.
Published on:
15 August, 2024
In a memo from Jane Verity and Charles Lister to Sue Cartwright, officials provided Lord Hunt a co-ordinated approach to problems associated with Hepatitis C treatment.
Published on:
15 August, 2024
In a memo from Lord Hunt to others, he proposed a co-ordinated package of care to those infected with HCV.
Published on:
15 August, 2024
Charles Lister in his statement to the Inquiry stated that Sandra Falconer noted that the Scottish Executive was seeking to maintain the common UK position.
Published on:
15 August, 2024
Charles Lister in his statement noted that campaigners from Manor House and Haemophilia Action UK staged a protest march demanding compensation.
Published on:
15 August, 2024
Charles Lister responded to questions by Yvette Cooper noting that it would be difficult to make payments to those with haemophilia without making payments to those infected via blood transfusion.
Published on:
15 August, 2024
In early July 2001, Yvette Cooper approved an amended line to take regarding ministers "reviewing the case for compensation".
Published on:
15 August, 2024
At a meeting of SNBTS and hemophilia directors Professor Ludlam explained 16 haemophilia patients treated with SNBTS Factor 8 had been infected with HTLV 3.
Published on:
30 September, 2024
At a meeting of SNBTS and heamophilia directors Dr Forbes spoke of findings relating to HTLV 3 antibody seroconversion in a comparative study of haemophilia patients in Glasgow and Denmark.
Published on:
30 September, 2024
At a meeting of SNBTS and haemophilia directors Dr Brenda Gibson reported five out of ten patients tested at the Royal Hospital for Sick Children (Yorkhill) were HIV positive.
Published on:
30 September, 2024
At a meeting of SNBTS and haemophilia directors it was agreed that patients should be informed about the recent findings in relation to patients with haemophilia being infected with HIV before additional publicity was given.
Published on:
30 September, 2024
In 1983 there was an increase in the use of commercial concentrates (200,000 units of Factorate for home treatment), although NHS concentrates remained the mainstay of treatment at the Glasgow Haemophilia Centre.
Published on:
30 September, 2024
In 1984, the use of commercial concentrates dropped again at the Glasgow Haemophilia Centre.
Published on:
30 September, 2024
Professor Gordon Lowe confirmed in his oral evidence that he became aware of AIDS cases in haemophiliacs in late 1982 from Professor Forbes who was initiating a study of immune abnormalities in patients with severe haemophilia. The conclusion of the study was that Scottish patients had immunological abnormalities similar to those in their US counterparts.
Published on:
30 September, 2024
Professor Goron Lowe stated in his oral evidence that Dr Forbes confirmed in his Penrose Inquiry evidence that blood was taken from 77 Scottish people between December 1983 and July 1984, and they were not told that their blood was being tested for HIV. None of the 12 patients who had tested positive had been told of their HIV test results.
Published on:
30 September, 2024
A study of immune abnormalities in patients with severe haemophilia resulted in the publication in of a paper entitled "Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate"? The study concluded that Scottish patients had immunological abnormalities similar to those in their US counterparts.
Published on:
30 September, 2024
It was recorded that 5 young homosexual men had contracted opportunistic infections such as pneumocystis, pneumonia, cryptococcosis or severe candidiasis.
Published on:
30 September, 2024
Dr Mayne wrote to the Lancet that the evolving HIV problem within the haemophilia population had "caused immeasurable distress to patients and to all physicians treating them. The Doctors concerned were guilty of one fault, namely that of ignorance."
Published on:
30 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2316
Page
2317
Page
2318
Page
2319
Current page
2320
Page
2321
Page
2322
Page
2323
Page
2324
…
Next page
Next
Last page
Last